- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00425867
PAR Family Polymorphisms and Placental Invasion Disorders
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Polymorphisms of Protease Activated Receptor 1 and adverse pregnancy outcomes Protease Activated Receptor 1 (PAR1), the main thrombin receptor on vascular cells (Coughlin,1999), plays a critical role in orchestrating human placentation based on temporally and spatially constrained PAR1 expression in the normal invasive trophoblasts (O'Brien et al, 2003) and its overexpression in pathological invasive trophoblast (Even-Ram et al, 2003).
Various proteases of the PAR family as well as matrix metalloproteinases have been implicated in ancillary regulation of cancer metastases and tumor-related angiogenesis. PAR1 in particular has been proposed to be involved in invasive processes of various cancers (Ruf & Mueller, 2006; Boire et al, 2005). Similarly, it might be surmised that remodeling of the placenta microenvironment as well as the requisites of trophoblast invasiveness may be PAR1 sensitive (Grisaru-Granovsky et al, 2005). Therefore, one might hypothesize that PAR1 gene variability may be involved in early placentation and that adverse pregnancy outcomes of the "placental syndromes" may have their origin in PAR1 dysregulation.
Study Design: This is a prospective case-control pilot study. Subject enrolment and data collection will be performed via the Admission Service of the Division for Maternal & Fetal Medicine in a large tertiary obstetrics department in Jerusalem, Israel. Demographic data including maternal characteristics, past reproductive history, and information about previous complications during pregnancy, delivery and the neonatal period will be culled. The blood samples will be collected at routine admission after obtaining informed consent by the physician on the floor.
Four groups are described: patients with spontaneous preterm delivery of a singleton before 35 weeks of gestation; patients with a singleton pregnancy complicated by preeclampsia diagnosed according the Working Group Criteria (2000); patients who deliver a small for gestational age (SGA) singleton defined as a birth weight below the 10th percentile for the gestational age according to the Israeli growth curves (Dollberg et al, 2005); and for comparison, patients who deliver a singleton at term with appropriate size for gestational age. Patients who suffer delivery with intrauterine fetal demise and/or neonates with malformations will be excluded.
Maternal and umbilical cord blood samples (in 0.11mol/l sodium tri citrate) will be paired. DNA will be prepared from white blood cells by standard techniques and subsequently stored at -4°C for batched analysis. The laboratory staff will be blinded as to the clinical status of the samples.
Polymorphism analysis will be performed for the following polymorphisms of the PAR1 gene: [-1426CT], [506 insertion of 13 bp],[IVS-14A/T]: as per standard PCR techniques using appropriate restriction endonucleases (Arnaud et l, 2000).
Study Type
Enrollment
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women with reccurent abortions unexplained
- Premature delicery
Exclusion Criteria:
- Term pregnancies
- Abortion that the cause is known
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sorina Grisaru, MD, Shaare Zedek Medical Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PAR1 polymorphisms
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Miscarriage, Recurrent
-
Fudan UniversityUnknown
-
Nanjing UniversityCompletedUnexplained Recurrent Miscarriage and Recurrent Implantation FailureChina
-
Rigshospitalet, DenmarkThe Ministry of Science, Technology and Innovation, DenmarkCompletedSecondary Recurrent MiscarriageDenmark
-
UMC UtrechtCompleted
-
Woman's Health University Hospital, EgyptTerminatedRecurrent Pregnancy LossesEgypt
-
Assiut UniversityCompleted
-
Ain Shams UniversityCompleted
-
Omar Mamdouh ShaabanCompleted
-
Abbott ProductsCompletedRecurrent MiscarriageAustria, Poland
-
National Cheng-Kung University HospitalMinistry of Science and Technology, TaiwanCompletedCare in Women With History of Recurrent Miscarriage
Clinical Trials on PAR1 polymoprhisms and placental invasion
-
Nourhan ElsadanyCompleted
-
Seoul National University HospitalRecruitingEfficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers (FUSIONIV)Cervical Cancer | Uterine CancerKorea, Republic of
-
Fundació Institut de Recerca de l'Hospital de la...Carlos III Health Institute; Spanish Clinical Research Network - SCReNCompleted
-
SanofiTerminatedCongestive Heart FailurePoland, Netherlands, Sweden, Denmark, Hungary, Norway
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingPlacental Elastography | Fetal Monitoring
-
University Hospital, LilleUnknownPolycystic Ovary SyndromeFrance
-
Helse Møre og Romsdal HFNorwegian University of Science and TechnologyRecruitingInfant Conditions | Cesarean SectionNorway
-
Sohag UniversityRecruitingTelocytes in Umbilical Cord of Pregnancies Complicated by Chronic Hypertension, Gestational Hypertension and PreeclampsiaEgypt
-
Koç UniversityThe Scientific and Technological Research Council of TurkeyRecruitingPreterm Birth | Microbial ColonizationTurkey